KLK3 and pachyonychia congenita: Considering that it is inconsistent with clinical practice, we also recommend subsequent researchers adopt a new PSA classification standard for elderly PC patients over 65 years of age: PSA <10 ng/ml,10-20 ng/ml,> 20 ng/ml, instead of 4 ng/ml as the intermediate value, which may avoid outcome bias.